Anika Therapeutics Inc. (ANIK) vs Canopy Growth Corporation (CGC)
- Anika Therapeutics Inc. ANIK 19.98 −3.43%
- Canopy Growth Corporation CGC 0.71 −4.05%
Anika Therapeutics Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $311.2M against $276.9M — 1.1× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against 5.33%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −80.4%) and the higher return on invested capital (−3.24% vs −17.2%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Canopy Growth Corporation on 6.
Valuation
Profitability
| Metric | ANIK | CGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 25.16% | 53.94% |
| Operating margin | (4.24%) | (54.89%) | 0.00% |
| Net margin | (3.14%) | (80.39%) | 0.00% |
| Free cash flow margin | 0.47% | (28.34%) | 0.00% |
| Return on equity | (2.66%) | (40.14%) | (0.40%) |
| Return on assets | (2.04%) | (23.54%) | (3.32%) |
| Return on invested capital | (3.24%) | (17.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack